Alnylam and Isis set up antisense JV Regulus Therapeutics
- Antisense, Oligonucleotides
- Large Molecule
- Includes Contract
- Intra-Biotech Deal
- Joint Venture
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.